Johnson & Johnson's experimental prostate cancer drug, JNJ-6143, has shown significant tumor shrinkage and reduced PSA levels ...

A groundbreaking study reveals that Amgen's Imdelltra, when combined with AstraZeneca's immunotherapy Imfinzi, significantly ...

Zymeworks has entered a global licensing agreement with Roche to develop and commercialize its experimental lung cancer drug ...

The inclusion of Dr. Naresh Trehan in a pharmaceutical marketing review panel faces backlash from patient groups over ...

Sun Pharma's Unolxcyt shows a significant objective response rate and durable cancer control for patients with advanced skin ...

Dr Reddy's Laboratories has introduced two new generic versions of Ozempic, named Obeda Pro and Obeda Plus, to address supply ...

AbbVie announced promising results for its experimental drug lutikizumab in reducing skin lesions from hidradenitis ...

Telitacicept met the study's main goal and largely preserved kidney function over two years, while patients on placebo saw a ...

The deal follows positive mid-stage results for Gilead's experimental pill for chronic bowel disease, emvistegrast, on Monday ...

Novartis presents disappointing data for remibrutinib, its oral multiple sclerosis drug, showing lower than anticipated ...

Dr Reddy’s Laboratories is set to resume supplies of its semaglutide generic, Obeda, following production disruptions, ...

Explore how cheap Chinese antibiotics threaten the survival of Europe's final major penicillin manufacturing facility in ...